Trials / Completed
CompletedNCT01157559
Efficacy and Safety With Ziprasidone in First-episode Psychosis
Efficacy and Safety With Ziprasidone in the Treatment of First-episode Schizophrenia Spectrum Disorder: Multi-center Study
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 27 (actual)
- Sponsor
- Chonbuk National University Hospital · Academic / Other
- Sex
- All
- Age
- 14 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to investigate the efficacy and safety of ziprasidone in patients with first episode psychosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ziprasidone | 8 week prospective study |
Timeline
- Primary completion
- 2008-06-01
- Completion
- 2010-05-01
- First posted
- 2010-07-07
- Last updated
- 2010-07-07
Locations
3 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01157559. Inclusion in this directory is not an endorsement.